Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study

Kong Vang, Jennifer Panich, Connie Folz, Hiral Patel, Nikhila Aimalla, Yuanli Lei, Thane Drier, Paige Hergenrother, Somto Nwaedozie, Chady A Leon

Open source

DOI
10.1177/10781552251349459
Published
2025-06-23
Container
Journal of Oncology Pharmacy Practice
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10781552251349459,
  title = {Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study},
  author = {Kong Vang and Jennifer Panich and Connie Folz and Hiral Patel and Nikhila Aimalla and Yuanli Lei and Thane Drier and Paige Hergenrother and Somto Nwaedozie and Chady A Leon},
  year = {2025},
  journal = {Journal of Oncology Pharmacy Practice},
  doi = {10.1177/10781552251349459},
  url = {https://doi.org/10.1177/10781552251349459}
}

RIS

TY  - JOUR
TI  - Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study
AU  - Kong Vang
AU  - Jennifer Panich
AU  - Connie Folz
AU  - Hiral Patel
AU  - Nikhila Aimalla
AU  - Yuanli Lei
AU  - Thane Drier
AU  - Paige Hergenrother
AU  - Somto Nwaedozie
AU  - Chady A Leon
PY  - 2025
JO  - Journal of Oncology Pharmacy Practice
DO  - 10.1177/10781552251349459
UR  - https://doi.org/10.1177/10781552251349459
ER  - 

APA

Vang, K., Panich, J., Folz, C., Patel, H., Aimalla, N., Lei, Y., Drier, T., Hergenrother, P., Nwaedozie, S., & Leon, C. A. (2025). Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552251349459

Source records